Fidelity's increased passive stake to 7.7% signals continued institutional interest, but as a 13G filer there is no activist intent. Monitor for any future conversion to a 13D filing, which would indicate a shift to active engagement.
VKTX drugs
VKTX drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $25.79entry
- T+1 · 11d ago +4.07%α +3.76% · $26.84
- T+5 · 5d ago +6.94%α +3.65% · $27.58
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G reporting beneficial ownership of 9,539,067 shares of Viking Therapeutics common stock as of September 30, 2026, representing 7.7% of shares outstanding. This is an increase from the prior filing by Vanguard Capital Management LLC, which reported 2,692,339 shares (5.0%) as of April 30, 2026. The filing is a routine passive stake update by a major institutional investor.
Key Financial Metrics
Key Facts
- FMR LLC (Fidelity) reported beneficial ownership of 9,539,067 shares of Viking Therapeutics common stock as of September 30, 2026
- The stake represents 7.7% of shares outstanding
- This is an amendment to Schedule 13G, indicating a passive investment intent
- The prior filing by Vanguard Capital Management LLC reported 2,692,339 shares (5.0%) as of April 30, 2026
- The filing date is November 5, 2026, with the ownership date as of September 30, 2026
Financial Impact
FMR LLC holds 9,539,067 shares, valued at approximately $734.5 million based on the $3.3B market cap and 7.7% stake
Risk Factors
- FMR LLC is a passive investor; no activist pressure or strategic changes expected from this filing
- The filing reflects ownership as of September 30, 2026; current holdings may differ
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002856 |
| Document: 0000315066-26-002856-index-headers.html | 0000315066-26-002856 |
| Document: 0000315066-26-002856-index.html | 0000315066-26-002856 |
| Document: 0000315066-26-002856.txt | 0000315066-26-002856 |
Track record
13 reports on VKTX
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +31.38% at T+20 after the Sep 24, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Viewing Entry $25.79 to $26.84 Now $26.80 +3.92% ▲ +4.07% +3.76% vs SPY
- Oct 28, 202619d ago 8-K Neutral 5/10 Entry $26.86 to $27.28 Now $26.80 −0.22% ▲ +1.56% +3.34% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bearish 4/10 Entry $24.40 to $24.21 Now $26.80 −9.84% ▲ +0.78% +1.49% vs SPY
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $25.83 to $24.40 Now $26.80 +3.76% ▼ −5.54% −5.01% vs SPY
- Sep 28, 20267w ago 8-K Mixed 6/10 Entry $31.81 to $32.60 Now $26.80 −15.75% ▲ +2.48% +2.69% vs SPY
- Sep 24, 20267w ago 424B5 Bearish 5/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
- Sep 24, 20267w ago 424B5 Bearish 6/10 Entry $35.56 to $33.03 Now $26.80 +24.63% ▲ +7.11% +6.37% vs SPY
- Sep 23, 20267w ago 424B5 Neutral 4/10 Entry $36.75 to $35.56 Now $26.80 −27.07% ▼ −3.24% −3.78% vs SPY
- Sep 23, 20267w ago 424B5 Bearish 6/10 Entry $36.75 to $35.56 Now $26.80 +27.07% ▲ +3.24% +3.78% vs SPY
- Sep 22, 20267w ago 8-K Bullish 7/10 Entry $40.85 to $41.65 Now $26.80 −34.39% ▲ +1.96% +2.68% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers